About this trial
This study aims to determine the minimum effective volume of bupivacaine required for the serratus posterior superior intercostal plane (SPSIP) block in patients undergoing video-assisted thoracoscopic surgery (VATS). The SPSIP block is an ultrasound-guided regional anesthesia technique used to provide postoperative pain relief after thoracic surgery.
Using a stepwise dose-adjustment method, the volume of local anesthetic will be increased or decreased based on the effectiveness of the block in each patient. The main outcome of the study is to identify the volume that provides effective pain control in 50% of patients. The results may help optimize pain management while minimizing drug exposure.
Eligibility criteria
Qualifiers
Age 18 years or older
Scheduled for elective video-assisted thoracoscopic surgery (VATS)
American Society of Anesthesiologists (ASA) physical status I-III
Planned to receive ultrasound-guided serratus posterior superior intercostal plane block for postoperative analgesia
Disqualifiers
Refusal to participate in the study
Known allergy or contraindication to local anesthetics
Infection at the block injection site
Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia
Trial design
Treatments tested in this trial
- Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block
Treatment groups
Sponsors and collaborators
Bursa City Hospital
Lead sponsor
Ulusoy, Emre, M.D.
Collaborator